Metformin and Malignant Tumors: Not Over the Hill [Response to Letter].
作者信息
Leng Weiling, Jiang Juan, Chen Bing, Wu Qinan
机构信息
Endocrinology Department, The First Affiliated Hospital of the Third Military Medical University (Army Medical University), Chongqing, People's Republic of China.
Endocrinology and Nephrology Department, Chongqing University Cancer Hospital and Chongqing Cancer Institute and Chongqing Cancer Hospital, Chongqing, People's Republic of China.
出版信息
Diabetes Metab Syndr Obes. 2021 Sep 8;14:3947-3948. doi: 10.2147/DMSO.S336807. eCollection 2021.
Abstract
摘要
相似文献
1
Metformin and Malignant Tumors: Not Over the Hill [Response to Letter].二甲双胍与恶性肿瘤：并非日薄西山 [对来信的回应]
Diabetes Metab Syndr Obes. 2021 Sep 8;14:3947-3948. doi: 10.2147/DMSO.S336807. eCollection 2021.
2
Metformin and Malignant Tumors: Not Over the Hill.二甲双胍与恶性肿瘤：并非日薄西山。
Diabetes Metab Syndr Obes. 2021 Aug 17;14:3673-3689. doi: 10.2147/DMSO.S326378. eCollection 2021.
3
Metformin and Malignant Tumors: Not Over the Hill: A Short Comment [Letter].二甲双胍与恶性肿瘤：尚未过时：简短评论[信函]
Diabetes Metab Syndr Obes. 2021 Sep 7;14:3839-3840. doi: 10.2147/DMSO.S335574. eCollection 2021.
4
Metformin inhibits development of colon malignant tumors induced by 1,2-dimethylhydrazine in rats.二甲双胍可抑制大鼠中由1,2 - 二甲基肼诱导的结肠恶性肿瘤的发展。
Dokl Biol Sci. 2016 May;468(1):97-100. doi: 10.1134/S0012496616030017. Epub 2016 Jul 14.
5
Metformin effects on malignant cells and healthy PBMC; the influence of metformin on the phenotype of breast cancer cells.二甲双胍对恶性细胞和健康外周血单核细胞的影响；二甲双胍对乳腺癌细胞表型的影响。
Pathol Oncol Res. 2015 Jul;21(3):605-12. doi: 10.1007/s12253-014-9864-9. Epub 2014 Oct 29.
6
Response to Letter to the Editor: Metformin in colorectal cancer: A match ruled by MiR26b?致编辑的信的回复：二甲双胍与结直肠癌：由MiR26b主导的一场较量？
Cancer Epidemiol. 2020 Feb;64:101626. doi: 10.1016/j.canep.2019.101626. Epub 2019 Nov 16.
7
[Metformin: the overlap of diabetology and oncology].[二甲双胍：糖尿病学与肿瘤学的交叉领域]
Vnitr Lek. 2013 Aug;59(8):738-42.
8
[Research Advance in Anti-lung Cancer Mechanism of Metformin].[二甲双胍抗肺癌机制的研究进展]
Zhongguo Fei Ai Za Zhi. 2020 Apr 20;23(4):282-285. doi: 10.3779/j.issn.1009-3419.2020.102.02.
9
Multimodality imaging assessments of response to metformin therapy for breast cancer in nude mice.多模态成像评估二甲双胍治疗裸鼠乳腺癌的疗效。
Chin Med J (Engl). 2013;126(19):3717-22.
10
Response to Letter to the Editor on comments on Use of metformin and risk of kidney cancer in patients with type 2 diabetes Chin-Hsiao Tseng, Eur J Cancer, 2016, No. 52, pp. 19-25.对《致编辑的信》的回复，关于对2型糖尿病患者使用二甲双胍与患肾癌风险的评论 曾庆孝，《欧洲癌症杂志》，2016年，第52卷，第19 - 25页
Eur J Cancer. 2016 Jul;61:159-60. doi: 10.1016/j.ejca.2016.03.064. Epub 2016 Apr 25.
本文引用的文献
1
Metformin and Malignant Tumors: Not Over the Hill.二甲双胍与恶性肿瘤：并非日薄西山。
Diabetes Metab Syndr Obes. 2021 Aug 17;14:3673-3689. doi: 10.2147/DMSO.S326378. eCollection 2021.
2
Cancer Biology and Prevention in Diabetes.糖尿病中的癌症生物学与预防
Cells. 2020 Jun 2;9(6):1380. doi: 10.3390/cells9061380.
3
Metformin Use and the Risk of Cancer in Patients with Diabetes: A Nationwide Sample Cohort Study.二甲双胍的使用与糖尿病患者癌症风险：一项全国性样本队列研究。
Cancer Prev Res (Phila). 2020 Feb;13(2):195-202. doi: 10.1158/1940-6207.CAPR-19-0427. Epub 2019 Nov 7.
4
Challenges and perspectives in the treatment of diabetes associated breast cancer.糖尿病相关乳腺癌治疗的挑战与展望。
Cancer Treat Rev. 2018 Nov;70:98-111. doi: 10.1016/j.ctrv.2018.08.004. Epub 2018 Aug 10.
5
Metformin for cancer prevention: a reason for optimism.二甲双胍用于癌症预防：值得乐观的理由。
Lancet Oncol. 2016 Apr;17(4):407-409. doi: 10.1016/S1470-2045(16)00006-1. Epub 2016 Mar 3.
6
Association of type 2 diabetes mellitus and the risk of colorectal cancer: A meta-analysis and systematic review.2型糖尿病与结直肠癌风险的关联：一项荟萃分析与系统评价
World J Gastroenterol. 2015 May 21;21(19):6026-31. doi: 10.3748/wjg.v21.i19.6026.
7
The effects of metformin on ovarian cancer: a systematic review.二甲双胍对卵巢癌的影响：系统评价。
Int J Gynecol Cancer. 2013 Nov;23(9):1544-51. doi: 10.1097/IGC.0b013e3182a80a21.
8
Diabetes and cancer--an AACE/ACE consensus statement.糖尿病与癌症——美国临床内分泌医师协会/美国内分泌学会共识声明
Endocr Pract. 2013 Jul-Aug;19(4):675-93. doi: 10.4158/EP13248.CS.
9
Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials.成人接受二甲双胍治疗的癌症结局和全因死亡率：随机临床试验的系统评价和协作荟萃分析。
Diabetologia. 2012 Oct;55(10):2593-2603. doi: 10.1007/s00125-012-2653-7. Epub 2012 Aug 10.
10
Diabetes mellitus, hyperglycaemia and cancer.糖尿病、高血糖和癌症。
Diabetes Metab. 2010 Jun;36(3):182-91. doi: 10.1016/j.diabet.2010.04.001.
Zotero 插件